Tag: Clinical trials
Search News
Cancer-killing virus treatment shows promise in brain tumour trial
8th November 2024
An innovative cancer-killing virus shows promise for tackling glioblastoma, an aggressive type of brain tumour, according to new results from a phase I clinical trial co-led by researchers at Barts Cancer Institute.
Read more
BCI part of new UK-wide cancer immunotherapy initiative
7th October 2024
Researchers from Barts Cancer Institute, Queen Mary University of London are part of a nationwide team of universities, hospitals and industry collaborating on a new platform to understand immunotherapy response and side effects in cancer.
Read more
Groundbreaking trials reveal improved survival for two hard-to-treat cancers
16th September 2024
Prof Tom Powles and Prof Peter Schmid announced practice-changing results at ESMO 2024
Read more
International Clinical Trials Day – how Barts clinical trials are changing cancer care
20th May 2024
To mark International Clinical Trials Day 2024, we’re spotlighting some of our clinical trial work and how it is helping to transform the lives of people with cancer.
Read more
Thomas Powles named in TIME’s list of the 100 most influential people in global health this year
2nd May 2024
Professor Powles has been recognised for his transformative clinical work delivering a life-extending treatment for severe bladder cancer.
Read more
Immunotherapy drug improves survival for people with kidney cancer in landmark clinical trial
19th April 2024
Professor Tom Powles and team reveal first successful adjuvant therapy for kidney cancer in 50 years.
Read more